Cryo-Cell International (NYSEAMERICAN:CCEL) Issues Earnings Results

Cryo-Cell International (NYSEAMERICAN:CCEL) announced its quarterly earnings data on Monday. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.04, Yahoo Finance reports. Cryo-Cell International had a negative net margin of 29.38% and a negative return on equity of 56.27%. The firm had revenue of $8.04 million during the quarter.

Cryo-Cell International Stock Up 1.0 %

NYSEAMERICAN:CCEL traded up $0.07 on Wednesday, reaching $7.25. 1,401 shares of the company’s stock traded hands, compared to its average volume of 9,252. The stock has a market cap of $58.73 million, a PE ratio of -6.19 and a beta of 0.47. Cryo-Cell International has a 12 month low of $3.67 and a 12 month high of $9.50.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.